Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beiyun Chen

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Pathology Research International|December 29, 2010
Testing for HER2 in Breast Cancer: A Continuing EvolutionSejal Shah, Beiyun Chen
Mayo Clinic Proceedings|January 8, 2021
Papillary Thyroid Carcinoma BRAF ImmunopositivityLori A Erickson, Beiyun Chen
Mayo Clinic Proceedings|September 5, 2021
Metaplastic Breast CancerBeiyun Chen, Lori A Erickson
Mayo Clinic Proceedings|January 8, 2022
Desmoid Tumor and Multiple Colon AdenomasLori A Erickson, Beiyun Chen
Mayo Clinic Proceedings|November 6, 2020
Fibroadenoma of the BreastLori A Erickson, Beiyun Chen
Mayo Clinic Proceedings|April 5, 2021
Juvenile Papillomatosis of BreastBeiyun Chen, Lori A Erickson
American Journal of Clinical Pathology|April 22, 2005
Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?Rohit Bhargava, Priti Lal, Beiyun Chen
American Journal of Clinical Pathology|May 19, 2005
HER-2/neu and topoisomerase IIa gene amplification and protein expression in invasive breast carcinomas: chromogenic in situ hybridization and immunohistochemical analysesRohit Bhargava, Priti Lal, Beiyun Chen
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 13, 2004
Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinomaRohit Bhargava, Priti Lal, Beiyun Chen
Mayo Clinic Proceedings|September 4, 2022
Anastomosing HemangiomaBeiyun Chen, Ruifeng Guo, Lori A Erickson
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Pathology Research International|December 29, 2010
Testing for HER2 in Breast Cancer: A Continuing EvolutionSejal Shah, Beiyun Chen
Mayo Clinic Proceedings|January 8, 2021
Papillary Thyroid Carcinoma BRAF ImmunopositivityLori A Erickson, Beiyun Chen
Mayo Clinic Proceedings|September 5, 2021
Metaplastic Breast CancerBeiyun Chen, Lori A Erickson
Mayo Clinic Proceedings|January 8, 2022
Desmoid Tumor and Multiple Colon AdenomasLori A Erickson, Beiyun Chen
Mayo Clinic Proceedings|November 6, 2020
Fibroadenoma of the BreastLori A Erickson, Beiyun Chen
Mayo Clinic Proceedings|April 5, 2021
Juvenile Papillomatosis of BreastBeiyun Chen, Lori A Erickson
American Journal of Clinical Pathology|April 22, 2005
Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization?Rohit Bhargava, Priti Lal, Beiyun Chen
American Journal of Clinical Pathology|May 19, 2005
HER-2/neu and topoisomerase IIa gene amplification and protein expression in invasive breast carcinomas: chromogenic in situ hybridization and immunohistochemical analysesRohit Bhargava, Priti Lal, Beiyun Chen
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 13, 2004
Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinomaRohit Bhargava, Priti Lal, Beiyun Chen
Mayo Clinic Proceedings|September 4, 2022
Anastomosing HemangiomaBeiyun Chen, Ruifeng Guo, Lori A Erickson
Pageof 7